349 related articles for article (PubMed ID: 31330170)
21. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
[TBL] [Abstract][Full Text] [Related]
23. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation and treatment of portal hypertension].
Brůha R; Petrtýl J
Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788
[TBL] [Abstract][Full Text] [Related]
25. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension.
Paternostro R; Bardach C; Hofer BS; Scheiner B; Schwabl P; Asenbaum U; Ba-Ssalamah A; Scharitzer M; Bucscis T; Simbrunner B; Bauer D; Trauner M; Mandorfer M; Reiberger T; Lampichler K
Liver Int; 2021 Apr; 41(4):799-809. PubMed ID: 33290614
[TBL] [Abstract][Full Text] [Related]
27. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.
Mandorfer M; Kozbial K; Schwabl P; Freissmuth C; Schwarzer R; Stern R; Chromy D; Stättermayer AF; Reiberger T; Beinhardt S; Sieghart W; Trauner M; Hofer H; Ferlitsch A; Ferenci P; Peck-Radosavljevic M
J Hepatol; 2016 Oct; 65(4):692-699. PubMed ID: 27242316
[TBL] [Abstract][Full Text] [Related]
28. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
29. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
Manolakopoulos S; Triantos C; Theodoropoulos J; Vlachogiannakos J; Kougioumtzan A; Papatheodoridis G; Tzourmakliotis D; Karamanolis D; Burroughs AK; Archimandritis A; Raptis S; Avgerinos A
J Hepatol; 2009 Sep; 51(3):468-74. PubMed ID: 19616339
[TBL] [Abstract][Full Text] [Related]
30. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
Reverter E; Blasi A; Abraldes JG; Martínez-Palli G; Seijo S; Turon F; Berzigotti A; Balust J; Bosch J; García-Pagán JC
Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
[TBL] [Abstract][Full Text] [Related]
31. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
Kim JJ; Dasika NL; Yu E; Fontana RJ
J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
[TBL] [Abstract][Full Text] [Related]
32. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
Pind ML; Bendtsen F; Kallemose T; Møller S
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
[TBL] [Abstract][Full Text] [Related]
33. Surgical Risk Assessment in Patients with Chronic Liver Diseases.
Jadaun SS; Saigal S
J Clin Exp Hepatol; 2022; 12(4):1175-1183. PubMed ID: 35814505
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of 833 times measured hepatic venous pressure gradient].
Zhang MY; Wang GC; Huang GJ; Feng H; Wang LF; Zhang JY; Shi YJ; Zhang CQ
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):266-270. PubMed ID: 29996337
[No Abstract] [Full Text] [Related]
36. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
[TBL] [Abstract][Full Text] [Related]
37. Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis.
Leeming DJ; Veidal SS; Karsdal MA; Nielsen MJ; Trebicka J; Busk T; Bendtsen F; Krag A; Møller S
Scand J Gastroenterol; 2015 May; 50(5):584-92. PubMed ID: 25639675
[TBL] [Abstract][Full Text] [Related]
38. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T
J Gastroenterol Hepatol; 2019 Dec; 34(12):2164-2172. PubMed ID: 31062417
[TBL] [Abstract][Full Text] [Related]
39. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
[TBL] [Abstract][Full Text] [Related]
40. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension.
Raeven P; Baron-Stefaniak J; Simbrunner B; Stadlmann A; Schwabl P; Scheiner B; Schaden E; Eigenbauer E; Quehenberger P; Mandorfer M; Baron DM; Reiberger T
Hepatol Int; 2020 Dec; 14(6):1083-1092. PubMed ID: 33000389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
